Life Science Big News Roundup: Makers of Malboro Fund Lexaria’s Oral Nicotine Project; NanoSphere Signs Definitive Licensing Agreement with Delta 9 Cannabis Inc. Life Science Investing News
XBiotech Publishes Results in PLOS ONE for its True Human Antibody 514G3 Targeting S. aureus Biotech Investing
Ezutromid Significantly Reduced Muscle Damage in DMD Patients in 24-Week Interim Data From Summit’s PhaseOut DMD Clinical Trial Biotech Investing
Menlo Therapeutics Inc. Announces Pricing of Initial Public Offering of Common Stock Biotech Investing
Iovance Biotherapeutics Announces Preliminary Phase 2 Data for TIL Treatment in Head and Neck and Cervical Cancers Biotech Investing
Zosano Announces Results of Special Meeting of Stockholders and 1-for-20 Reverse Stock Split Pharmaceutical Investing
